BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28385129)

  • 1. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.
    Adinehbeigi K; Razi Jalali MH; Shahriari A; Bahrami S
    Pathog Glob Health; 2017 Jun; 111(4):176-185. PubMed ID: 28385129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
    Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
    Pujals G; Suñé-Negre JM; Pérez P; García E; Portus M; Tico JR; Miñarro M; Carrió J
    Parasitol Res; 2008 May; 102(6):1243-7. PubMed ID: 18278586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.
    Reis LES; Fortes de Brito RC; Cardoso JMO; Mathias FAS; Aguiar Soares RDO; Carneiro CM; de Abreu Vieira PM; Ramos GS; Frézard FJG; Roatt BM; Reis AB
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
    Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
    Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.
    Oliaee RT; Sharifi I; Bamorovat M; Keyhani A; Babaei Z; Salarkia E; Tavakoly R; Khosravi A; Mostafavi M; Sharifi F; Mousavi SM
    Int Immunopharmacol; 2020 Sep; 86():106704. PubMed ID: 32590317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
    Carrió J; Portús M
    BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
    Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
    Borborema SE; Osso Junior JA; Andrade Junior HF; Nascimento Nd
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):196-203. PubMed ID: 27192589
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Garcia AR; Oliveira DMP; Claudia F Amaral A; Jesus JB; Rennó Sodero AC; Souza AMT; Supuran CT; Vermelho AB; Rodrigues IA; Pinheiro AS
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1100-1109. PubMed ID: 31124384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain.
    Carrió J; Riera C; Gállego M; Portús M
    Acta Trop; 2001 May; 79(2):179-83. PubMed ID: 11369311
    [No Abstract]   [Full Text] [Related]  

  • 13. Sinergism between alkaloids piperine and capsaicin with meglumine antimoniate against Leishmania infantum.
    Vieira-Araújo FM; Macedo Rondon FC; Pinto Vieira ÍG; Pereira Mendes FN; Carneiro de Freitas JC; Maia de Morais S
    Exp Parasitol; 2018 May; 188():79-82. PubMed ID: 29625099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes.
    Khademvatan S; Adibpour N; Eskandari A; Rezaee S; Hashemitabar M; Rahim F
    Exp Parasitol; 2013 Oct; 135(2):208-16. PubMed ID: 23872452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
    Shokri A; Sharifi I; Khamesipour A; Nakhaee N; Fasihi Harandi M; Nosratabadi J; Hakimi Parizi M; Barati M
    Parasitol Res; 2012 Mar; 110(3):1113-7. PubMed ID: 21847598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases.
    Cosco D; Bruno F; Castelli G; Puleio R; Bonacci S; Procopio A; Britti D; Fresta M; Vitale F; Paolino D
    Macromol Biosci; 2021 Jul; 21(7):e2100046. PubMed ID: 34117834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved efficacy of meglumine antimoniate incorporated in anionic liposomes against Leishmania infantum infecting canine macrophages.
    Ortega V; Radaic A; de Jesus MB; de Paula E; Giorgio S
    J Pharm Pharmacol; 2022 Jun; 74(6):896-904. PubMed ID: 34289045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoenzyme characterization of Leishmania infantum toward checking the antioxidant activity of superoxide dismutase and glutathione peroxidase.
    Alishvandi M; Bahrami S; Rashidi S; Hatam G
    BMC Infect Dis; 2024 Feb; 24(1):208. PubMed ID: 38360592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.